A5037214558- Pain Mechanisms and Treatments
- Botulinum Toxin and Related Neurological Disorders
- Parkinson's Disease Mechanisms and Treatments
- Neurological Disorders and Treatments
- Systemic Lupus Erythematosus Research
- Atherosclerosis and Cardiovascular Diseases
- Peripheral Neuropathies and Disorders
- Epilepsy research and treatment
- Pancreatic function and diabetes
- Neurological and metabolic disorders
- Adipose Tissue and Metabolism
- Peptidase Inhibition and Analysis
- Analytical Methods in Pharmaceuticals
- Natural Antidiabetic Agents Studies
- Diabetes Treatment and Management
- Plant-based Medicinal Research
- Acute Ischemic Stroke Management
Taichung Veterans General Hospital
2022-2024
National Chung Hsing University
2022
National Taipei University
2022
Abstract Diabetes mellitus is a risk factor for Parkinson's disease (PD). While animal studies have supported the benefits of incretin-based therapies, including dipeptidyl peptidase-4 (DPP4) inhibitors, in PD, clinical research has yielded controversial results. This cohort study aimed to assess relationship between PD incidence and utilization DPP4 inhibitor diabetic patients. Using Taiwan's National Health Insurance Research Database from 2009 2018, patients receiving metformin plus at...
Poststroke epilepsy (PSE) is a common complication after ischemic stroke. This study investigates the association between use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and risk PSE in patients with
Previous studies showed conflicting relationship between hyperlipidemia, lipid-lowering therapy and diabetic peripheral neuropathy (DPN). As most of these works emerges from the Western Australian countries, our study aims to investigate whether hyperlipidemia or (LLT) is associated with DPN in Taiwanese patients type 2 diabetes (T2D).A cross-sectional, hospital-based observation adults T2D was conducted January October 2013. screened using Michigan Neuropathy Screening Instrument. Data were...
There are few data on the influence of lupus flare stroke risk in systemic erythematosus (SLE). In this study, we examined whether a severe further increases among SLE patients.Using Taiwan's National Health Insurance Research Database, conducted retrospective population-based cohort study from 2000 to 2016. Each patient with was matched non-SLE subject age, sex, and index date. A identified when an admitted for pulse therapy intravenous methylprednisolone greater than 250 mg single...
Background and purpose To analyse the long-term risk of ischaemic stroke clinical effects antithrombotics on haemorrhagic in patients with systemic lupus erythematosus (SLE). Methods A retrospective cohort study was conducted using a population-based database taken from Taiwan National Health Insurance Research Database. Patients SLE between 2000 2008 were registered matched two controls by index date, age, gender Charlson Comorbidity Index (CCI). These subjects followed until either event...
Our study aimed to assess glycemic variability by calculating the coefficients of variation (CV) for fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c) investigate their association with painful DPN in adult patients T2D.
Abstract Aims Previous studies showed conflicting relationship between hyperlipidemia, lipid-lowering therapy and diabetic peripheral neuropathy (DPN). As most of these works emerges from the Western Australian countries, our study aims to investigate whether hyperlipidemia or drugs is associated with risk DPN in Taiwanese patients type 2 diabetes (T2D). Methods A cross-sectional, hospital-based observation adults T2D was conducted January October 2013. screened using Michigan Neuropathy...